Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wilhelm rural pty ltd - zinc phosphide - bait - zinc phosphide ungrouped active 25.0 g/kg - vertebrate poison - canola | grain crop | legume crop | nut crop | pasture | safflowers | high intensity usage | rapeseed - mouse - mus spp.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - zinc phosphide - bait - zinc phosphide ungrouped active 25.0 g/kg - vertebrate poison - agricultural or horticultural situation | canola | grain crop | legume crop | nuts | pasture | safflowers | high intensity usage - mouse - mus spp.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bell laboratories, inc. - zinc phosphide; malathion - ready-to-use bait - zinc phosphide ungrouped active 20.0 g/kg; malathion organophosphorus other 0.11 g /kg - vertebrate poison - canola - see label | grain crop | legume crop | nut crop | pasture - refer to label for use | safflower - refer to label - rodent, rat or mouse | black rat/mouse | brown rat/mouse | mouse | rat | rodent | roof rat

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

redox limited - zinc sulfate heptahydrate - topical solution/suspension - zinc sulfate heptahydrate mineral-zinc active 980.0 g/kg - dermatological preps. - goat | sheep | billy | buck | capra hircus | doe | ewe | hogget | kid | lamb | ovine | ram | weaner | wether - bacterial prevention, cleansing or disin | mycotic dermatitis | disinfecting

Malta - English - Medicines Authority

fresenius kabi limited cestrian court, eastgate way, manor park, runcorn, cheshire wa7 1nt, united kingdom - chromic chloride, potassium iodide, copper chloride, ferric chloride, zinc chloride, manganese chloride, sodium fluoride, sodium molybdate, sodium selenite - concentrate for solution for infusion - chromic chloride 5.33 µg potassium iodide 16.6 µg copper chloride 340 µg ferric chloride 544 µg zinc chloride 1.36 mg manganese chloride 99 µg sodium fluoride 210 µg sodium molybdate 4.85 µg sodium selenite 10.5 µg - blood substitutes and perfusion solutions

Australia - English - Department of Health (Therapeutic Goods Administration)

care pharmaceuticals pty ltd - sodium chloride, quantity: 2.83 mg/ml; calcium carbonate, quantity: 200 microgram/ml (equivalent: calcium, qty 80 microgram/ml); potassium citrate, quantity: 1.46 mg/ml (equivalent: potassium, qty 529 microgram/ml); manganese sulfate monohydrate, quantity: 1.6 microgram/ml (equivalent: manganese, qty 0.507 microgram/ml); copper gluconate, quantity: 2.1 microgram/ml (equivalent: copper, qty 0.3 microgram/ml); zinc sulfate monohydrate, quantity: 5.5 microgram/ml (equivalent: zinc, qty 2 microgram/ml); glucose, quantity: 22 mg/ml; citric acid monohydrate, quantity: 4.31 mg/ml; ferrous sulfate, quantity: 3.13 microgram/ml (equivalent: iron, qty 1 microgram/ml); dried magnesium sulfate, quantity: 374 microgram/ml (equivalent: magnesium, qty 50 microgram/ml) - oral liquid - excipient ingredients: sodium benzoate; anthocyanins; potassium sorbate; purified water; invert syrup; acesulfame potassium; sucralose; maltodextrin; sulfur dioxide; colour; flavour - decrease/reduce/relieve symptoms of dehydration (linked indication:maintain/support body electrolyte balance; helps restore body electrolyte balance; decrease/reduce/relieve muscle cramps; helps enhance/improve/promote/increase physical/exercise performance)

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - moxifloxacin hydrochloride, quantity: 1.74 mg/ml - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; sodium chloride - moxifloxacin-baxter is indicated for treatment of adults who require initial i.v. therapy for the treatment of infections in the conditions: ? community acquired pneumonia (caused by susceptible organisms) ? acute exacerbations of chronic bronchitis when caused by organisms bacteriologically proven to be resistant to other classes of antibiotics or when there is intolerance to other antibiotics moxifloxacin-baxter is indicated for treatment of adults with severe and complicated skin and skin structure infections who require initial parenteral therapy, and who have intolerance to alternative agents, (especially penicillin allergy), and when caused by organisms known to be susceptible to moxifloxacin. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with moxifloxacin-baxter may be initiated, in some conditions, before results of these tests are known. once results become available, therapy should be continued with the most appropriate antibiotic therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

care pharmaceuticals pty ltd - sodium chloride, quantity: 2.83 mg/ml; glucose monohydrate, quantity: 22 mg/ml; calcium carbonate, quantity: 200 microgram/ml (equivalent: calcium, qty 80 microgram/ml); potassium citrate, quantity: 1.46 mg/ml (equivalent: potassium, qty 529 microgram/ml); manganese sulfate monohydrate, quantity: 1.6 microgram/ml (equivalent: manganese, qty 0.507 microgram/ml); copper gluconate, quantity: 2.1 microgram/ml (equivalent: copper, qty 0.3 microgram/ml); zinc sulfate monohydrate, quantity: 5.5 microgram/ml (equivalent: zinc, qty 2 microgram/ml); citric acid monohydrate, quantity: 4.31 mg/ml; ferrous sulfate, quantity: 3.13 microgram/ml (equivalent: iron, qty 1 microgram/ml); dried magnesium sulfate, quantity: 374 microgram/ml (equivalent: magnesium, qty 50 microgram/ml) - oral liquid - excipient ingredients: acesulfame potassium; purified water; sodium benzoate; sucralose; brilliant blue fcf; quinoline yellow; potassium sorbate; flavour - decrease/reduce/relieve symptoms of dehydration (linked indication:maintain/support body electrolyte balance; helps restore body electrolyte balance; decrease/reduce/relieve muscle cramps; helps enhance/improve/promote/increase physical/exercise performance)

United States - English - NLM (National Library of Medicine)

laboratoire aguettant - zinc gluconate trihydrate (unii: f2f0xu34wq) (zinc cation - unii:13s1s8sf37) - zinc cation 1 mg in 1 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: dibasic sodium phosphate dihydrate; sodium hydroxide; zinc chloride; phenol; hydrochloric acid; glycerol; water for injections; protamine sulfate; metacresol - the treatment of insulin-requiring diabetes.